Featured Posts
Study
A Free Market is the Best Medicine
Introduction The pharmaceutical supply market is seeing extraordinarily high levels of innovation and consumer-benefiting evolution. The combination of a competitive market for generic drugs,…
Blog
Congress considers micromanaging PBM finances
With the first reconciliation bill behind it, Congress is now looking to reform other aspects of the health care system. Pharmacy Benefit Manager…
Blog
Free the Economy podcast: Drug costs and benefits with Sally Pipes
In this week’s episode we cover reforms to the Endangered Species Act, attacks on US tech firms, nuclear power…
Search Posts
Medical Progress Today
Mayo v. Prometheus and Diagnostic Patents: What Does the Supreme Court Decision Really Mean?
I finally had a chance to read the Supreme Court's recent decision in the Mayo v. Prometheus Labs case, which invalided two patents claiming methods…
Medical Progress Today
The Orphan Drug Conundrum
It’s not a crisis. Yet. Bigger health care issues loom. Right now. There are still fortunes to be made. While it lasts. But one could…
Medical Progress Today
Seeking Solution to “Incredibly Complex” Issue of Drug Shortages
Medical Progress Today
The FDA vs. Commercial Speech
The ability of physicians to prescribe approved medicines for purposes not sanctioned by the Food and Drug Administration (FDA) is one of the most important…
Medical Progress Today
The 510(k) Program Should Be Saved, Not Scorned
Medical Progress Today